But an association with improved overall survival failed to reach statistical significance ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

New data show salvage focal therapy rivals surgery in radiorecurrent prostate cancer while reducing complications. Learn more about the findings.

Two types of androgen deprivation therapy (ADT) had different effects on coronary atherosclerosis in a small randomized trial ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

As Candel Therapeutics gears up for a planned U.S. approval push for its prostate cancer drug later this year, RTW ...

Adding metastasis-directed therapy (MDT) to standard of care was tied to improvements in several survival endpoints in oligometastatic prostate cancer, a recent analysis suggests.